ReviewMovement disorders : official journal of the Movement Disorder Society2012
The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.
Review in Movement disorders : official journal of the Movement Disorder Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Using non-invasive transcranial stimulation to improve motor and cognitive function in Parkinson's disease: a systematic review and meta-analysis.Scientific reports · 2017Pooled it
- Alteration of hippocampal parvalbumin interneurons underlies memory impairment in rat model of Parkinson's disease.Frontiers in behavioral neuroscience · 2025Article
- Naturalistic assessment of everyday multitasking in Parkinson's disease with and without mild cognitive impairment.The Clinical neuropsychologist · 2024Article
- Detecting Subtle Cognitive Impairment in Patients with Parkinson's Disease and Normal Cognition: A Novel Cognitive Control Challenge Task (C3T).Brain sciences · 2023Article
- The effect of URB597, exercise or their combination on the performance of 6-OHDA mouse model of Parkinson disease in the elevated plus maze, tail suspension test and step-down task.Metabolic brain disease · 2021Article
- Mitochondria-Endoplasmic Reticulum Crosstalk in Parkinson's Disease: The Role of Brain Renin Angiotensin System Components.Biomolecules · 2021Review
- Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson's disease.Journal of neurology · 2021Article
- Mechanistic interplay of various mediators involved in mediating the neuroprotective effect of daphnetin.Pharmacological reports : PR · 2021Review
- Neurocognitive profile of patients with X-linked dystonia-parkinsonism.Journal of neural transmission (Vienna, Austria : 1996) · 2021Article
- Multisite non-invasive brain stimulation in Parkinson's disease: A scoping review.NeuroRehabilitation · 2021Article
- Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.Human brain mapping · 2019Article
- Catechol-o-methyltransferase inhibitor tolcapone improves learning and memory in naïve but not in haloperidol challenged rats.Iranian journal of basic medical sciences · 2019Article
- Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.Frontiers in pharmacology · 2019Review
- Article
- Parkinson's disease as a system-level disorder.NPJ Parkinson's disease · 2016Review
- Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease.Journal of neurology · 2015Article
- Effects of levodopa on regional cerebral metabolism and blood flow.Movement disorders : official journal of the Movement Disorder Society · 2015Review
- How does the bilingual experience sculpt the brain?Nature reviews. Neuroscience · 2014Review
- The neurobiological basis of cognitive impairment in Parkinson's disease.Movement disorders : official journal of the Movement Disorder Society · 2014Review
- Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease.The Lancet. Neurology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Patients with Parkinson's disease (PD) often develop a spectrum of cognitive symptoms that can evolve into dementia. Dopamine (DA) replacement medications, though improving motor symptoms, can exert both positive and negative effects on cognitive ability, depending on the severity of the disease and the specific skill being tested. By considering the behavioral and clinical aspects of disease- and treatment-mediated changes in cognition alongside the pathophysiology of PD, an understanding of the factors that govern the heterogeneous expression of cognitive impairment in PD is beginning to emerge. Here, we review the neuroimaging studies revealing the neural correlates of cognitive changes after DA loss and DA replacement as well as those that may accompany the conversion from milder stages of cognitive impairment to frank dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.